JP2002525060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002525060A5 JP2002525060A5 JP2000570334A JP2000570334A JP2002525060A5 JP 2002525060 A5 JP2002525060 A5 JP 2002525060A5 JP 2000570334 A JP2000570334 A JP 2000570334A JP 2000570334 A JP2000570334 A JP 2000570334A JP 2002525060 A5 JP2002525060 A5 JP 2002525060A5
- Authority
- JP
- Japan
- Prior art keywords
- opgl
- polypeptide
- nucleic acid
- animal
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199801164 | 1998-09-15 | ||
| US10289698P | 1998-10-02 | 1998-10-02 | |
| US199801164 | 1998-10-02 | ||
| US60/102,896 | 1998-10-02 | ||
| PCT/DK1999/000481 WO2000015807A1 (en) | 1998-09-15 | 1999-09-13 | Method for down-regulating osteoprotegerin ligand activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002525060A JP2002525060A (ja) | 2002-08-13 |
| JP2002525060A5 true JP2002525060A5 (cg-RX-API-DMAC7.html) | 2006-11-02 |
Family
ID=26065320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000570334A Pending JP2002525060A (ja) | 1998-09-15 | 1999-09-13 | オステオプロテゲリンリガンド活性をダウンレギュレートする方法 |
Country Status (24)
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA003636B1 (ru) * | 1997-04-16 | 2003-08-28 | Амген Инк. | Остеопротегеринсвязующие белки и рецепторы |
| US6316408B1 (en) * | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| HRP20010188A2 (en) * | 1998-09-15 | 2002-04-30 | Pharmexa As | Method for down-regulating osteoprotegerin ligand activity |
| GB9908263D0 (en) * | 1999-04-13 | 1999-06-02 | Binding Site The Limited | Eliciting improved immune responses |
| WO2000067777A1 (en) * | 1999-05-07 | 2000-11-16 | Biofan Pty Ltd | A method of prophylaxis and treatment and agents useful therefor |
| CA2647796A1 (en) * | 1999-07-28 | 2001-02-08 | The Trustees Of The University Of Pennsylvania | Method of inhibiting osteoclast activity |
| US6673771B1 (en) | 1999-07-28 | 2004-01-06 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclast activity |
| AU7615600A (en) * | 1999-09-27 | 2001-04-30 | Eli Lilly And Company | Osteoclast differentiation factor regulatory region |
| AUPQ314799A0 (en) * | 1999-09-29 | 1999-10-21 | University Of Western Australia, The | Bone cell factor |
| HRP20020721B1 (en) * | 2000-02-21 | 2012-04-30 | H. Lundbeck A/S | Novel method for down-regulation of amyloid |
| WO2001062284A2 (en) * | 2000-02-21 | 2001-08-30 | Pharmexa A/S | Novel method for down-regulation of amyloid |
| US20030103978A1 (en) * | 2000-02-23 | 2003-06-05 | Amgen Inc. | Selective binding agents of osteoprotegerin binding protein |
| WO2001062932A1 (en) * | 2000-02-23 | 2001-08-30 | Amgen Inc. | Antagonistic selective binding agents of osteoprotegerin binding protein |
| AU2001266604A1 (en) * | 2000-05-26 | 2001-12-11 | Smith Kline Beecham Corporation | Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| AU2001288342A1 (en) * | 2000-08-21 | 2002-03-04 | Smith Kline Beecham Corporation | Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| WO2002024228A1 (fr) * | 2000-09-21 | 2002-03-28 | Center For Advanced Science And Technology Incubation, Ltd. | Méthode de régulation de la formation d'ostéoclastes |
| AU9303001A (en) | 2000-09-22 | 2002-04-02 | Immunex Corp | Screening assays for agonists or antagonists of receptor activat or of nf-kb |
| US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
| CA2441538A1 (en) * | 2001-03-22 | 2002-10-17 | Barnes-Jewish Hospital | Stimulation of osteogenesis using rank ligand fusion proteins |
| DE60235418D1 (de) | 2001-04-03 | 2010-04-01 | Nestle Sa | Osteoprotegerin in Milch |
| TR201809678T4 (tr) * | 2001-06-26 | 2018-07-23 | Amgen Fremont Inc | Opgl ye karşi antikorlar. |
| MY144532A (en) * | 2001-08-20 | 2011-09-30 | Lundbeck & Co As H | Novel method for down-regulation of amyloid |
| US20030109444A1 (en) * | 2001-10-12 | 2003-06-12 | Jonathan Lam | Bone anti-resorptive compounds |
| JP4336467B2 (ja) * | 2001-10-15 | 2009-09-30 | 株式会社林原生物化学研究所 | 破骨細胞形成抑制因子の産生を調節し得る物質のスクリーニング方法 |
| EP1560843A4 (en) * | 2002-01-04 | 2006-09-06 | Xencor Inc | NEW VARIANTS OF RANKL PROTEIN |
| US7399829B2 (en) | 2002-01-04 | 2008-07-15 | Xencor, Inc. | Variants of RANKL protein |
| US7381792B2 (en) | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
| AU2003243139B2 (en) | 2002-04-05 | 2007-06-21 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| US6921538B2 (en) * | 2002-05-10 | 2005-07-26 | Allergan, Inc. | Therapeutic treatments for neuropsychiatric disorders |
| MXPA05006147A (es) | 2002-12-10 | 2005-08-26 | Schering Plough Ltd | Ligando del activador del receptor de nf-kb de canino, y metodos para preparar y usar el mismo. |
| KR20070058426A (ko) * | 2004-06-02 | 2007-06-08 | 사이토스 바이오테크놀로지 아게 | 비-인간 tnf-펩티드의 담체 콘쥬게이트의 의학적 용도 |
| US20080107597A1 (en) * | 2006-01-12 | 2008-05-08 | Anaptys Biosciences, Inc. | Isolation of antibodies that cross-react and neutralize rankl originating from multiple species |
| WO2008088594A2 (en) * | 2007-01-12 | 2008-07-24 | Anaptysbio, Inc. | Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species |
| CN101434656B (zh) * | 2007-11-16 | 2011-12-14 | 首都医科大学 | Opg-hsp70融合蛋白的制备方法及用途 |
| WO2009154770A2 (en) * | 2008-06-18 | 2009-12-23 | The Texas A & M University System | Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage |
| WO2011128892A2 (en) * | 2010-04-12 | 2011-10-20 | Protea Vaccine Technologies Ltd. | Modified forms of pneumococcal surface immunogenic protein b (psipb) |
| CN107286245B (zh) * | 2016-04-11 | 2021-10-08 | 北京普纳生物科技有限公司 | Pd-l1和pd-l2重组蛋白及其用途 |
| CN107286244B (zh) * | 2016-04-11 | 2021-10-08 | 北京普纳生物科技有限公司 | 抗免疫检查点pd-l1和pd-l2肿瘤疫苗 |
| CN108498786A (zh) * | 2018-02-13 | 2018-09-07 | 南昌大学第二附属医院 | 载骨保护素的缓释纳米粒及其制备方法和应用 |
| KR102154637B1 (ko) * | 2018-11-12 | 2020-09-10 | 조선대학교산학협력단 | Rankl의 돌연변이체, 및 이를 포함하는 골다공증 예방 또는 치료용 약학 조성물 |
| US20250304708A1 (en) * | 2022-09-07 | 2025-10-02 | The Regents Of The University Of California | Treatment of cancer by blockade of osteoprotegerin |
| KR20250118303A (ko) * | 2024-01-29 | 2025-08-06 | 주식회사 아크젠바이오사이온스 | Rankl의 돌연변이체 및 이를 포함하는 백신 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1237764B (it) * | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| DE4496393T1 (de) | 1993-08-27 | 1996-11-21 | Dow Chemical Co | Verfahren zur Trennung von Enantiomeren |
| EP0755444A4 (en) * | 1994-04-01 | 1998-01-14 | Univ Utah | MOLECULAR CLONING AND EXPRESSION OF AN INDUCTIBLE PROTEASOME ACTIVATOR BY INTERFERON GAMMA |
| US6340459B1 (en) * | 1995-12-01 | 2002-01-22 | The Trustees Of Columbia University In The City Of New York | Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients |
| US6369027B1 (en) * | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
| PT1114864E (pt) * | 1996-12-13 | 2008-10-08 | Schering Corp | Antigénios de superfície de células de mamífero, reagentes relacionados |
| ATE497001T1 (de) * | 1996-12-23 | 2011-02-15 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
| US5843678A (en) * | 1997-04-16 | 1998-12-01 | Amgen Inc. | Osteoprotegerin binding proteins |
| EA003636B1 (ru) * | 1997-04-16 | 2003-08-28 | Амген Инк. | Остеопротегеринсвязующие белки и рецепторы |
| HRP20010188A2 (en) * | 1998-09-15 | 2002-04-30 | Pharmexa As | Method for down-regulating osteoprotegerin ligand activity |
-
1999
- 1999-09-13 HR HR20010188A patent/HRP20010188A2/hr not_active Application Discontinuation
- 1999-09-13 JP JP2000570334A patent/JP2002525060A/ja active Pending
- 1999-09-13 ES ES99942778T patent/ES2239457T3/es not_active Expired - Lifetime
- 1999-09-13 IL IL14158899A patent/IL141588A0/xx unknown
- 1999-09-13 SK SK306-2001A patent/SK3062001A3/sk not_active Application Discontinuation
- 1999-09-13 CZ CZ2001789A patent/CZ2001789A3/cs unknown
- 1999-09-13 HK HK02100128.3A patent/HK1040261A1/zh unknown
- 1999-09-13 EP EP99942778A patent/EP1114166B1/en not_active Expired - Lifetime
- 1999-09-13 CN CN99810872A patent/CN1318105A/zh active Pending
- 1999-09-13 NZ NZ510508A patent/NZ510508A/en unknown
- 1999-09-13 TR TR2001/00737T patent/TR200100737T2/xx unknown
- 1999-09-13 PT PT99942778T patent/PT1114166E/pt unknown
- 1999-09-13 CA CA002343654A patent/CA2343654A1/en not_active Abandoned
- 1999-09-13 AT AT99942778T patent/ATE291628T1/de not_active IP Right Cessation
- 1999-09-13 WO PCT/DK1999/000481 patent/WO2000015807A1/en not_active Ceased
- 1999-09-13 AU AU56173/99A patent/AU754971B2/en not_active Ceased
- 1999-09-13 PL PL346698A patent/PL196790B1/pl not_active IP Right Cessation
- 1999-09-13 EE EEP200100149A patent/EE200100149A/xx unknown
- 1999-09-13 HU HU0103578A patent/HUP0103578A3/hu unknown
- 1999-09-13 DE DE69924392T patent/DE69924392T2/de not_active Expired - Fee Related
- 1999-09-13 KR KR1020017003379A patent/KR100671036B1/ko not_active Expired - Fee Related
- 1999-09-13 ID IDW20010822A patent/ID28386A/id unknown
- 1999-09-15 US US09/396,937 patent/US6645500B1/en not_active Expired - Fee Related
-
2001
- 2001-02-22 IL IL141588A patent/IL141588A/en not_active IP Right Cessation
- 2001-03-14 NO NO20011304A patent/NO20011304L/no not_active Application Discontinuation
-
2003
- 2003-09-17 US US10/664,801 patent/US20040115199A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Theisen et al. | Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | |
| CA2170236C (en) | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes | |
| CN108778322B (zh) | 铜绿假单胞菌pcrv连接的抗原疫苗 | |
| JP4087898B2 (ja) | 免疫原性に乏しい抗原と合成ペプチド担体との結合体およびそれらからなるワクチン | |
| KR860700090A (ko) | 어드헤신(Adhesin)항원 | |
| JP3267333B2 (ja) | 融合タンパク質 | |
| JPH03173830A (ja) | ワクチン組成物 | |
| Dale et al. | Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. | |
| JP2003506325A5 (cg-RX-API-DMAC7.html) | ||
| TW202039587A (zh) | 供合成胜肽免疫原作為免疫刺激劑的人工混雜t輔助細胞抗原決定位 | |
| JPH08503602A (ja) | 弱毒化細菌における組換え融合タンパク質の発現 | |
| HRP20010900A2 (en) | Method for down-regulating gdf-8 activity | |
| AU707083B2 (en) | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes | |
| ES2236718T3 (es) | Proteina portadora de efecto adyuvante, complejo inmunogenico que la contiene, su procedimiento de preparacion, secuencia nucleotidica y vacuna. | |
| Taubman et al. | Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries | |
| JP2006503017A5 (cg-RX-API-DMAC7.html) | ||
| EP0365646B1 (en) | Synthetic peptides from streptococcal m protein and vaccines prepared therefrom | |
| US5824309A (en) | Recombinant gas vesicles and uses thereof | |
| WO1997020854A9 (en) | Recombinant gas vesicles and uses thereof | |
| ZA200302628B (en) | Method for down-regulating IgE. | |
| Kozuka et al. | Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity | |
| WO2004024183B1 (en) | Immunization against autologous ghrelin | |
| US20240139304A1 (en) | P aeruginosa pcrv-linked antigen vaccines | |
| JP2004529881A (ja) | 合成ワクチン剤 | |
| US6602507B1 (en) | Synthetic peptides from streptococcal M protein and vaccines prepared therefrom |